Showing results for IRB

Biomed Refresher 2 – History and Ethical Principles
Describes the ethical principles of respect for persons, beneficence, and justice from the Belmont Report. Presents a case study with a discussion ide...
FDA Updates on Cancer Clinical Trial Eligibility Criteria
Introduction The Food and Drug Administration (FDA) has announced the availability of two draft guidance documents that could reduce potential risk...
Biomed Refresher 2 – Regulations and Process
Summarizes the module Basic Institutional Review Board (IRB) Regulations and Review Process. Describes the regulatory definition of “research” as ...
NIH Requests Public Input on New Controlled-Access Data Policy and Updates to Genomic Data Sharing
Introduction The National Institutes of Health (NIH) has issued Notice NOT-OD-26-023, Request for Information on Draft NIH Controlled-Access Data Pol...
Recap of CITI Program's 2022 Content Updates
Overview 2022 was a busy and exciting year for CITI Program. As 2023 kicks off, CITI Program is proud to share a review of this past year's updates t...
Advancing Ethics and Innovation: Celebrating Clinical Trials Day with CITI Program
Overview Every year on May 20, the world recognizes Clinical Trials Day, a time to celebrate the extraordinary contributions of clinical research pro...
Critical Regulations and Oversight Bodies
This module summarizes ethical principles governing clinical research. It provides an overview of the FDA’s structure, jurisdiction, and regulatory ...
COVID-19 and Human Research Protection Programs
Presented by: Brenda L. Ruotolo, BA - Columbia University; Challace D. Pahlevan-Ibrekic, MS - Northwell Health Learning Objectives: Explor...
1 56 57 58 59 60 85

Can't Find What You're Looking For?

Search Support Center for additional results